1nrg
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:1nrg.png|left|200px]] | ||
- | |||
{{STRUCTURE_1nrg| PDB=1nrg | SCENE= }} | {{STRUCTURE_1nrg| PDB=1nrg | SCENE= }} | ||
- | |||
===Structure and Properties of Recombinant Human Pyridoxine-5'-Phosphate Oxidase=== | ===Structure and Properties of Recombinant Human Pyridoxine-5'-Phosphate Oxidase=== | ||
+ | {{ABSTRACT_PUBMED_12824491}} | ||
- | + | ==Disease== | |
+ | [[http://www.uniprot.org/uniprot/PNPO_HUMAN PNPO_HUMAN]] Defects in PNPO are the cause of pyridoxine-5'-phosphate oxidase deficiency (PNPO deficiency) [MIM:[http://omim.org/entry/610090 610090]]; also known as PNPO-related neonatal epileptic encephalopathy. The main feature of neonatal epileptic encephalopathy is the onset within hours of birth of a severe seizure disorder that does not respond to anticonvulsant drugs and can be fatal. Seizures can cease with the administration of PLP, being resistant to treatment with pyridoxine. | ||
+ | |||
+ | ==Function== | ||
+ | [[http://www.uniprot.org/uniprot/PNPO_HUMAN PNPO_HUMAN]] Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP).<ref>PMID:12824491</ref> | ||
==About this Structure== | ==About this Structure== | ||
Line 14: | Line 16: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:012824491</ref><references group="xtra"/> | + | <ref group="xtra">PMID:012824491</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Ko, T P.]] | [[Category: Ko, T P.]] |
Revision as of 10:54, 24 March 2013
Contents |
Structure and Properties of Recombinant Human Pyridoxine-5'-Phosphate Oxidase
Template:ABSTRACT PUBMED 12824491
Disease
[PNPO_HUMAN] Defects in PNPO are the cause of pyridoxine-5'-phosphate oxidase deficiency (PNPO deficiency) [MIM:610090]; also known as PNPO-related neonatal epileptic encephalopathy. The main feature of neonatal epileptic encephalopathy is the onset within hours of birth of a severe seizure disorder that does not respond to anticonvulsant drugs and can be fatal. Seizures can cease with the administration of PLP, being resistant to treatment with pyridoxine.
Function
[PNPO_HUMAN] Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP).[1]
About this Structure
1nrg is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Musayev FN, Di Salvo ML, Ko TP, Schirch V, Safo MK. Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase. Protein Sci. 2003 Jul;12(7):1455-63. PMID:12824491
- ↑ Musayev FN, Di Salvo ML, Ko TP, Schirch V, Safo MK. Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase. Protein Sci. 2003 Jul;12(7):1455-63. PMID:12824491
Categories: Homo sapiens | Ko, T P. | Musayev, F N. | Safo, M K. | Salvo, M L.di. | Schirch, V. | Fmn | Oxidase | Oxidoreductase | Plp | Pyridoxine-5'-phosphate